Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah June 4, 2025 Next Post S&P 500 Bullish Patterns: Are Higher Highs Ahead? June 4, 2025 Related Posts Multiple High Antimony Soil Anomalies Discovered at Armidale June 11, 2025 Widespread Natural Rutile Observed Throughout the Central Rutile Tenement Package June 11, 2025 Leadership Streamlining and Cost Reductions June 11, 2025